These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 9198247)

  • 21. Cryo-Electron Microscopy Structure of the αIIbβ3-Abciximab Complex.
    Nešić D; Zhang Y; Spasic A; Li J; Provasi D; Filizola M; Walz T; Coller BS
    Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):624-637. PubMed ID: 31969014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In Vitro Measurement and Modeling of Platelet Adhesion on VWF-Coated Surfaces in Channel Flow.
    Qi QM; Dunne E; Oglesby I; Schoen I; Ricco AJ; Kenny D; Shaqfeh ESG
    Biophys J; 2019 Mar; 116(6):1136-1151. PubMed ID: 30824114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Administration of eptifibatide during endovascular treatment of ruptured cerebral aneurysms reduces the rate of thromboembolic events.
    Sedat J; Chau Y; Gaudard J; Suissa L; Lachaud S; Lonjon M
    Neuroradiology; 2015 Feb; 57(2):197-203. PubMed ID: 25326169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is eptifibatide a safe and effective rescue therapy in thromboembolic events complicating cerebral aneurysm coil embolization? Single-center experience in 42 cases and review of the literature.
    Sedat J; Chau Y; Mondot L; Chemla R; Lonjon M; Padovani B
    Neuroradiology; 2014 Feb; 56(2):145-53. PubMed ID: 24281387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Andes virus regulation of cellular microRNAs contributes to hantavirus-induced endothelial cell permeability.
    Pepini T; Gorbunova EE; Gavrilovskaya IN; Mackow JE; Mackow ER
    J Virol; 2010 Nov; 84(22):11929-36. PubMed ID: 20844033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenic hantaviruses direct the adherence of quiescent platelets to infected endothelial cells.
    Gavrilovskaya IN; Gorbunova EE; Mackow ER
    J Virol; 2010 May; 84(9):4832-9. PubMed ID: 20181715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Andes virus recognition of human and Syrian hamster beta3 integrins is determined by an L33P substitution in the PSI domain.
    Matthys VS; Gorbunova EE; Gavrilovskaya IN; Mackow ER
    J Virol; 2010 Jan; 84(1):352-60. PubMed ID: 19846530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraarterial reteplase and intravenous abciximab for treatment of acute ischemic stroke. A preliminary feasibility and safety study in a non-human primate model.
    Qureshi AI; Suri MF; Ali Z; Ringer AJ; Boulos AS; Nakada MT; Alberico RA; Martin LB; Guterman LR; Hopkins LN
    Neuroradiology; 2005 Nov; 47(11):845-54. PubMed ID: 16205896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nitric oxide, platelet function, myocardial infarction and reperfusion therapies.
    Alonso D; Radomski MW
    Heart Fail Rev; 2003 Jan; 8(1):47-54. PubMed ID: 12652159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intraarterially administered abciximab as an adjuvant thrombolytic therapy: report of three cases.
    Kwon OK; Lee KJ; Han MH; Oh CW; Han DH; Koh YC
    AJNR Am J Neuroradiol; 2002 Mar; 23(3):447-51. PubMed ID: 11901016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycoprotein IIb/IIIa receptor antagonists: clinical pharmacology in cardiovascular diseases of aging.
    Sebastian M; Makkar R
    Drugs Aging; 1999 Sep; 15(3):207-18. PubMed ID: 10503813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet PlA2 polymorphism and thromboembolic events: from inherited risk to pharmacogenetics.
    Goldschmidt-Clermont PJ; Roos CM; Cooke GE
    J Thromb Thrombolysis; 1999 Aug; 8(2):89-103. PubMed ID: 10436139
    [No Abstract]   [Full Text] [Related]  

  • 33. Cellular entry of hantaviruses which cause hemorrhagic fever with renal syndrome is mediated by beta3 integrins.
    Gavrilovskaya IN; Brown EJ; Ginsberg MH; Mackow ER
    J Virol; 1999 May; 73(5):3951-9. PubMed ID: 10196290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New antiplatelet agents: platelet GPIIb/IIIa antagonists.
    Coller BS; Anderson K; Weisman HF
    Thromb Haemost; 1995 Jul; 74(1):302-8. PubMed ID: 8578476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized trial of a GPIIb/IIIa platelet receptor blocker in refractory unstable angina. European Cooperative Study Group.
    Simoons ML; de Boer MJ; van den Brand MJ; van Miltenburg AJ; Hoorntje JC; Heyndrickx GR; van der Wieken LR; de Bono D; Rutsch W; Schaible TF
    Circulation; 1994 Feb; 89(2):596-603. PubMed ID: 7508826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of GPIIb/IIIa inhibitors in cardiovascular medicine.
    Ahrens I; Peter K; Bode C
    Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):233-42. PubMed ID: 15030283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The anti-GPIIb-IIIa agents: fundamental and clinical aspects.
    Coller BS; Anderson KM; Weisman HF
    Haemostasis; 1996 Oct; 26 Suppl 4():285-93. PubMed ID: 8979134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".
    Reverter JC; Béguin S; Kessels H; Kumar R; Hemker HC; Coller BS
    J Clin Invest; 1996 Aug; 98(3):863-74. PubMed ID: 8698879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GPIIb/IIIa antagonists: pathophysiologic and therapeutic insights from studies of c7E3 Fab.
    Coller BS
    Thromb Haemost; 1997 Jul; 78(1):730-5. PubMed ID: 9198247
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.